Ureaplasma vaccine and antibodies
US9913887B2 · kind B2 · utility
0Cited by
19References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 14, 2015 |
| Grant date | Mar 13, 2018 |
| Priority date | — |
| Expiry date | Dec 14, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2469/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention encompasses methods and compositions for Ureaplasma infection prevention and/or treatment. In specific cases, the invention concerns vaccines for Ureaplasma, including DNA vaccines. In certain embodiments, the invention regards vaccines directed towards the multiple-banded antigen(s) of Ureaplasma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.